Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.

Talatinian A, Chow SL, Heywood JT.

Pharmacotherapy. 2012 Sep;32(9):827-37. doi: 10.1002/j.1875-9114.2012.01104.x. Review.

PMID:
22949142
2.

Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.

Zannad F, Gattis Stough W, Rossignol P, Bauersachs J, McMurray JJ, Swedberg K, Struthers AD, Voors AA, Ruilope LM, Bakris GL, O'Connor CM, Gheorghiade M, Mentz RJ, Cohen-Solal A, Maggioni AP, Beygui F, Filippatos GS, Massy ZA, Pathak A, Piña IL, Sabbah HN, Sica DA, Tavazzi L, Pitt B.

Eur Heart J. 2012 Nov;33(22):2782-95. doi: 10.1093/eurheartj/ehs257. Review.

3.

[Aldosterone receptor blockade after acute myocardial infarction with heart failure].

Bauersachs J, Ertl G.

Med Klin (Munich). 2006 Jun 15;101(6):458-66. Review. German.

PMID:
16767569
4.

Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).

Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B; EMPHASIS-HF Investigators..

J Am Coll Cardiol. 2013 Oct 22;62(17):1585-93. doi: 10.1016/j.jacc.2013.04.086.

5.

Integrating traditional and emerging treatment options in heart failure.

Nolan PE Jr.

Am J Health Syst Pharm. 2004 May 1;61 Suppl 2:S14-22. Review.

PMID:
15160834
6.

Aldosterone antagonism and congestive heart failure: a new look at an old therapy.

Thohan V, Torre-Amione G, Koerner MM.

Curr Opin Cardiol. 2004 Jul;19(4):301-8. Review.

PMID:
15218387
7.

[The role of aldosterone-antagonists in the treatment of congestive heart failure].

Fügedi K.

Orv Hetil. 2005 Apr 3;146(14):645-8. Review. Hungarian.

PMID:
15889538
8.

Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.

Butler J, Ezekowitz JA, Collins SP, Givertz MM, Teerlink JR, Walsh MN, Albert NM, Westlake Canary CA, Carson PE, Colvin-Adams M, Fang JC, Hernandez AF, Hershberger RE, Katz SD, Rogers JG, Spertus JA, Stevenson WG, Sweitzer NK, Tang WH, Stough WG, Starling RC.

J Card Fail. 2012 Apr;18(4):265-81. doi: 10.1016/j.cardfail.2012.02.005.

PMID:
22464767
9.

Race influences the safety and efficacy of spironolactone in severe heart failure.

Vardeny O, Cavallari LH, Claggett B, Desai AS, Anand I, Rossignol P, Zannad F, Pitt B, Solomon SD; Randomized Aldactone Evaluation Study (RALES) Investigators..

Circ Heart Fail. 2013 Sep 1;6(5):970-6. doi: 10.1161/CIRCHEARTFAILURE.113.000530.

11.

Optimizing care of heart failure after acute MI with an aldosterone receptor antagonist.

Verma A, Solomon SD.

Curr Heart Fail Rep. 2007 Dec;4(4):183-9. Review.

PMID:
18221614
12.

More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.

Aaronson K.

Health News. 2003 May;9(5):4. No abstract available.

PMID:
12739453
13.

Aldosterone antagonists in heart failure.

Guglin M, Kristof-Kuteyeva O, Novotorova I, Pratap P.

J Cardiovasc Pharmacol Ther. 2011 Jun;16(2):150-9. doi: 10.1177/1074248410387606. Review.

PMID:
21160084
14.
15.

Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.

Adams KF Jr.

Am J Health Syst Pharm. 2004 May 1;61 Suppl 2:S4-13. Review.

PMID:
15160833
16.

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure.

Nappi JM, Sieg A.

Vasc Health Risk Manag. 2011;7:353-63. doi: 10.2147/VHRM.S13779. Review.

17.

Aldosterone-receptor antagonists in heart failure: insights after EMPHASIS-HF.

Jacob MS, Tang WH.

Curr Heart Fail Rep. 2011 Mar;8(1):7-13. doi: 10.1007/s11897-010-0046-0.

PMID:
21207206
18.

New treatment option for heart failure patients: eplerenone.

Southworth MR, Cavallari LH.

J Cardiovasc Nurs. 2004 Nov-Dec;19(6):390-5. Review.

PMID:
15529060
19.

[Aldosterone antagonists for all patients with heart failure?].

Bauersachs J.

MMW Fortschr Med. 2009 Apr 9;151(15):33-5. German. No abstract available.

PMID:
19728679
20.

New therapy update. Inspra (eplerenone tablets).

Kloner RA.

Congest Heart Fail. 2003 Nov-Dec;9(6):341-2. No abstract available.

Items per page

Supplemental Content

Support Center